Florida Cancer Specialists

Summary

Florida Cancer Specialists is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer, Pancreatic Cancer and other specialties. Florida Cancer Specialists is involved with conducting 126 clinical trials across 148 conditions. There are 8 research doctors associated with this hospital, such as Viralkumar Bhanderi, Shachar Peles, Todd Gersten, and Eric Harris.

Top PIs

Clinical Trials running at Florida Cancer Specialists

Colorectal Cancer

Breast Cancer

Endometrial Cancer

Lung Cancer

Pancreatic Cancer

Chronic Lymphocytic Leukemia

Cancer

Multiple Myeloma

Non-Small Cell Lung Cancer

Ovarian Cancer

Amivantamab + Chemotherapy vs Cetuximab + Chemotherapy

for Colorectal Cancer

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, and irinotecan hydrochloride (FOLFIRI) versus cetuximab and mFOLFOX6 or FOLFIRI in adult participants with Kirsten rat sarcoma viral oncogene homolog (KRAS)/ Neuroblastoma RAS viral oncogene homolog (NRAS) and v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) wild type (WT) unresectable or metastatic left-sided colorectal cancer.

Recruiting

2 awards

Phase 3

4 criteria

Amivantamab + FOLFIRI

for Colorectal Cancer

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, and irinotecan hydrochloride (FOLFIRI) versus either cetuximab or bevacizumab and FOLFIRI given to participants with Kirsten rat sarcoma viral oncogene/ neuroblastoma RAS viral oncogene homolog (KRAS/ NRAS) and v-raf murine sarcoma viral oncogene homolog B (BRAF) wild-type recurrent, unresectable or metastatic colorectal cancer who have previously received chemotherapy.

Recruiting

2 awards

Phase 3

4 criteria

ART0380

for Advanced Cancer

This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more about the side effects of ART0380 alone and in combination with gemcitabine or irinotecan * Learn more about the effectiveness of ART0380 alone and in combination with gemcitabine or irinotecan

Recruiting

1 award

Phase 1 & 2

14 criteria